All posts by imreal

DiabetesSisters Board of Directors Announce Interim CEO


Michele Polz, Interim CEO

“Thank you to the Board for this tremendous honor and Anna for building a solid foundation. DiabetesSisters is on a growth trajectory as we expand our reach into communities nationwide, empowering women living with diabetes to take charge of their health and well-being.” – Michele Polz, Interim CEO

Anna Norton, MS, has announced her decision to step down as Chief Executive Officer of the organization, effective March 31, 2023. She will remain active in the health advocacy community.

The Board of Directors has named Michele Polz interim Chief Executive Officer effective March 31. Ms. Polz’s roots are deeply connected to DiabetesSisters, first as an industry partner responsible for its initial funding in 2009 and later joining the Board of Directors in 2016, serving as Chair of the Board from 2020-2021. She has driven the organization’s vision and mission toward its success.

Over the last eight years, the DiabetesSisters team led by Ms. Norton has worked collaboratively to elevate the organization into a vital resource for women living with diabetes. Highlights include:

  • building a Board of Directors to include the representation and interests of those with diabetes;
  • orchestrating virtual and in-person programming to reflect the needs of over half a million women through conferences, seminars, and online and printed resources in English, Spanish, Bengali, Gujarati, and Hindi, as well as launching a five-city outreach program to reflect the diabetes needs of African American, Hispanic/Latino and Indian population;
  • creating a membership program to include the needs of industry partners and DiabetesSisters, working with institutions of higher learning to drive research, and collaborating with other nonprofits to expand reach and knowledge of the intersection of diabetes, heart disease, and kidney disease;
  • aligning the organization with a long-term strategic growth map to meet the demands of the marketplace while securing the organization with financial footing to carry out its strategic plans; and
  • exploring new technologies with Digital Health & Artificial Intelligence partners.

Deborah Greenwood, Ph.D., RN, BC-ADM, CDCES, FADCES, DiabetesSisters’ Chair of the Board, said, “DiabetesSisters is grateful for Anna’s dedication and determination to flourish the organization. Her leadership has provided local, national, and international recognition as a leading diabetes-focused organization for women. The Board is confident that Ms. Polz’s experience and expertise will continue to elevate DiabetesSisters during this transition period. DiabetesSisters is searching for the next CEO to carry on the mission and drive DiabetesSisters into new strategic growth areas.”

Michele Polz, Interim CEO, said, “thank you to the Board for this tremendous honor and Anna for building a solid foundation. DiabetesSisters is on a growth trajectory as we expand our reach into communities nationwide, empowering women living with diabetes to take charge of their health and well-being. I look forward to working with the Board, DiabetesSisters community members, and industry partners to drive strategic growth and plan during this transition period.”

About DiabetesSisters:

A 501(c)(3) nonprofit, DiabetesSisters, is the only national organization focusing exclusively on women with diabetes. Our mission is to improve the health and quality of life of women living with and at risk of diabetes and to advocate on their behalf. DiabetesSisters has a 50,000+ member peer network that unites women with diabetes for support, education, and advocacy. Signature programs include monthly peer support meetings (PODS Meetups); the Welcoming Diversity, Elevating Voices Program; the annual Leadership Institute for volunteer peer support leaders; online expert articles, blog posts, and forums. For more information, visit diabetessisters.org.

Share article on social media or email:

Catalent Launches New Oral Developability Assessment and Manufacturing Solution to Advance Targeted Protein Degrader Programs


Targeted protein degraders have the potential to revolutionize new small molecule therapies, but if they are to be successful oral treatments, they require a rational approach to development and a comprehensive toolkit of proven technologies.

Catalent, the leader in enabling the development and supply of better treatments for patients worldwide, today announced the launch of the ProteoSuiteSM Oral suite, which allows the rational selection of orally developable targeted protein degrader (TPD) candidates and their advancement into clinical trials. These emerging therapeutic modalities are typically highly potent and present novel oral bioavailability challenges to formulators.

The new ProteoSuite Oral platform leverages Catalent’s successful 90-year track record of advancing thousands of complex molecules for oral drug development, including experience with multiple protein degrader programs, together with the development of custom TPD-specific assays and physiologically based pharmacokinetic (PBPK) and developability models. Customers using the service will benefit from the identification of those orally developable drug candidates with the greatest chance of success, and a development path to the clinic with consideration of the necessary advanced formulation technologies such as lipid-based delivery and amorphous solid dispersions, as well as manufacturing, specialty handling, and integrated clinical supply capabilities to accommodate these highly potent molecules.

Targeted protein degraders show significant promise in therapeutic areas such as oncology and beyond, but because of their complex structures, and physico-chemical properties, achieving satisfactory oral exposure can be challenging. They also present additional formulation and handling challenges.

“Targeted protein degraders have the potential to revolutionize new small molecule therapies, but if they are to be successful oral treatments, they require a rational approach to development and a comprehensive toolkit of proven technologies to address their ‘not so small’ characteristics and potency,” said Julien Meissonnier, Catalent’s Vice President and Chief Scientific Officer. “This new service provides customers with a logical and comprehensive development path, access to Catalent’s multi-center manufacturing capabilities designed to handle highly potent compounds, and its experience in scaling up and advancing successful products to market.”

Catalent’s network of early phase development sites includes facilities in St. Petersburg, Florida, San Diego, and Somerset, New Jersey, in the U.S., as well as Nottingham, U.K., and Beinheim, France. Development of targeted protein degraders at these sites will be supported by analytical, scale up and commercial sites with specific capabilities in handling potent drug products in Greenville, North Carolina, Kansas City, Missouri, Winchester, Kentucky, St. Petersburg, Beinheim, and Schorndorf and Eberbach in Germany.

About Catalent

Catalent is the global leader in enabling pharma, biotech, and consumer health partners to optimize product development, launch, and full life-cycle supply for patients around the world. With broad and deep scale and expertise in development sciences, delivery technologies, and multi-modality manufacturing, Catalent is a preferred industry partner for personalized medicines, consumer health brand extensions, and blockbuster drugs.

Catalent helps accelerate over 1,000 partner programs and launch over 150 new products every year. Its flexible manufacturing platforms at over 50 global sites supply around 80 billion doses of nearly 8,000 products annually. Catalent’s expert workforce of approximately 18,000 includes more than 3,000 scientists and technicians.

Headquartered in Somerset, New Jersey, the company generated nearly $5 billion in revenue in its 2022 fiscal year. For more information, visit http://www.catalent.com.

More products. Better treatments. Reliably supplied.™

Share article on social media or email:

Explore how Innovations in Technology are Improving Life Sciences


News Image

An upcoming segment of Advancements with Ted Danson will discover how technology is being used to redefine continuous validation throughout the life sciences industry.

With a look at the rapid adoption of cloud technology, viewers will learn about the importance of validating cloud applications and why there is a need to update current toolsets and validation approaches.

Audiences will learn how developments in technology are providing continuous validation for the life science industry, creating efficiency throughout life cycle management. Spectators will see how xLM is using automation to remove mundane tasks and improve compliance and other services throughout the sector.

In addition, the show will explore how the technology offers cost efficient validation that saves time and delivers validated, real-time access to cloud technology.

“Validating cloud applications can be a daunting task – considering the frequency of patches, upgrades, and releases. We look forward to exploring how Valimation’s continuous validation paradigm is revolutionizing the mundane task of validation,” said Richard Lubin, senior producer for the Advancements series.

About Valimation:

xLM – Continuous Validation is a technology firm based in the Jacksonville, FL. Its managed service is governed by a cutting-edge Quality Management System built on ISO 9001:2015, 21 CFR Part 11, Annex 11 and GxPs. xLM is a subsidiary of ValiMation Inc., an established name in the GxP and validation-related consulting space serving big and small Life Sciences companies globally since 1996.

For more information, visit: http://www.continuousvalidation.com.

About Advancements and DMG Productions:

Advancements is an information-based educational television series that explores recent developments taking place across several industries and economies. Shining a light on important issues and topics impacting society today, the series features the cutting-edge improvements, state-of-the-art technologies, and innovative solutions responsible for shaping, molding, and transforming our world.

Backed by experts in various fields, DMG Productions is dedicated to education and advancement, and to consistently producing commercial-free, educational programming for viewers and networks.

For more information, please visit http://www.AdvancementsTV.com or call 866-496-4065.

Share article on social media or email:

Injured Police Officer Receives Life-Changing Donation of Wheelchair Accessible Vehicle


Officer Dustin Moody and his family receive a red carpet introduction to their new BraunAbility wheelchair van, made possible by community and business donations.

Indiana police officer Dustin Moody was paralyzed in a terrible line-of-duty crash in June 2022 while trying to get an impaired driver off the streets. Since then, he has fought through extensive rehabilitation to get back to his wife Emily and their two beautiful kids, but they still had many obstacles to overcome to return to a normal life, including needing a wheelchair-accessible van, modifications to their home, and the loss of Emily’s income as a teacher as she focuses on being home to assist him and to care for their two beautiful children during his recovery process.

On March 28th at Superior Van & Mobility on the south side of Indianapolis, Officer Moody and his family were presented with a new modified van. This van will allow the whole family to get out of the house and regain their independence.

The Carver Toyota dealership in nearby Columbus generously donated the van chassis that was converted for wheelchair accessibility by BraunAbility. The finished BraunAbility Toyota Hybrid arrived at Superior Van & Mobility’s Indianapolis location, where the final customized fittings for Officer Moody were completed. Installation of Q-Straint retractable belts will ensure Officer Moody’s wheelchair is secure while he’s in the vehicle. Superior will be the servicing dealer for the mobility equipment and mobility conversion related vehicle elements in the future.

UpLift Johnson County joined with the Central Indiana Police Foundation in a fundraising effort to give this hometown hero and his family a new start.

Wendy McClellan, Executive Director for UpLift Johnson County said, “Thank you to all of those who donated, shared social media posts, and told friends and family about Officer Moody. We especially want to thank Carver Toyota of Columbus and BraunAbility for their donation and hard work to customize this van for exactly what the Moodys needed.”

###

ABOUT UPLIFT JOHNSON COUNTY 501(C)(3)

UpLift Johnson County is a service organization founded on the principle of “see a need, seek to fill it.” We give everyday people a resource to find volunteer opportunities or to nominate those in our community who may need assistance. We saw so many needs that needed to be filled but there was no single place to go for assistance or to find volunteers. So we created a place where other non-profits and individuals can come partner with us and fill needs in our community.

For more information on UpLift Johnson County and who we uplift, visit UpLiftJoCo.org.

###

ABOUT CENTRAL INDIANA POLICE FOUNDATION 501(C)(3)

Community-led and connected to police officers throughout Central Indiana, CIPF is agile in meeting needs as they arise and leveraging community resources to assist with public safety concerns in the community. CIPF provides an opportunity for individuals and the business community to show their thanks and support of the brave men and women who serve our community each day through contributions of time, talent and treasure. CIPF aims to meet the growing needs of local police officers including their health and welfare, safety, and community efficacy.

For more information on CIPF, visit CPIF.foundation.

###

ABOUT BraunAbility

BraunAbility is the world’s leading manufacturer of mobility transportation solutions, including wheelchair-accessible vehicles, wheelchair lifts and seating, storage and securement products. Founded over 50 years ago by Ralph Braun, an entrepreneur who spent most of his life in a wheelchair, the company has grown into the most well-known and trusted name in the mobility industry, bringing independence to millions of individuals across the world. BraunAbility is a wholly owned subsidiary of Patricia Industries, a division of Investor AB Group. For more information on BraunAbility, visit braunability.com.

Share article on social media or email:

Medical Spa Expert Dr. Alonso Martin Joins Exclusive Haute Beauty Network


News Image

A personalized approach is used to develop each client’s wellness program that may include the anti-aging and brain peptide, Emsculpt Neo, and facial rejuvenation.

Alonso Martin, MD is a board-certified physician focused on the results obtained when art and innovation meet beauty and longevity. He started his career at UCLA as a neuroscientist, where he studied the effects of antioxidants on longevity. Today, his practice offers the latest in non-invasive facial and body rejuvenation. He is recognized for delivering youthful and natural results that make his clients feel extraordinary. His medical practice focuses on medical aesthetics and award-winning wellness treatments that prevent muscle and bone loss.

He created the AM Longevity Method, a compilation of wellness principles and applications combined with Emsculpt Neo, an award-winning technology that grows new muscles and eliminates visceral fat. This technology is used by NFL athletes and many A-list celebrities for health optimization, strength, and longevity. For those looking to improve their sexual performance, he offers Emsella, a non-invasive treatment to improve sexual function and urinary incontinence.

Prior to opening his own practice, Dr. Martin worked as a primary care doctor treating age-related diseases such as obesity, high cholesterol, diabetes, depression, anxiety, hormone disorders, high blood pressure, chronic pain as well as autoimmune conditions. As non-invasive aesthetic treatments began emerging in the early 2000s, he was naturally drawn to this innovative field. In 2013, he trained with the American Association of Aesthetic Medicine and Surgery in Beverly Hills, an experience that changed his life forever. From then onward, he committed to additional years of injectable training and changed his focus from pharmaceutical treatments to prevention and wellness.

His area of expertise includes cosmetic dermatology with a focus on injectable neuromodulators (Botox, Daxxify, Dysport, Xeomin) and fillers. In addition, he offers 100% natural skin rejuvenation using PRF (Platelet-Rich Fibrin), a regenerative product obtained from the patient’s own blood. PRF rejuvenates the skin, stimulates collagen production, and reduces signs of aging such as wrinkles, fine lines, sun damage, and loose skin. His longevity practice includes the use of peptide therapy, also known as “strings of amino acids” that act as the building blocks for essential proteins in your body. A personalized approach is used to develop each client’s wellness program that may include the anti-aging and brain peptide, Emsculpt Neo, and facial rejuvenation.

We provide white glove aesthetic and wellness treatments. Today, his practice offers the latest modalities in non-invasive facial and body rejuvenation as well as longevity treatments with Emsculpt Neo, infrared light, cryotherapy, and PRF (platelet-rich fibrin). His practice will continue to add the latest in bio-optimization technologies that are safe and validated by science. Our medical concierge is always available via telemedicine for our limited clientele worldwide.

Dr. Martin earned his MD degree from Michigan State University and holds a B.Sc. in Neuroscience from UCLA. He trained at the University of California, Irvine Hospital in Family Medicine, where he treated patients of all ages. He is licensed in Florida and California and meets with clients in Miami Beach, FL, and Laguna Beach, CA. He is dedicated to philanthropy and is a contributing member of The Ronald McDonald House and other charitable organizations.

Learn more about Dr. Alonso Martin by visiting: https://hauteliving.com/hautebeauty/member/dr-alonso-martin/

ABOUT HAUTE BEAUTY NETWORK:

Haute Beauty is affiliated with the luxury lifestyle publication Haute Living. As a section of Haute Living magazine, Haute Beauty covers the latest advancements in beauty and wellness, providing readers with expert advice on aesthetic and reconstructive treatments through its network of acclaimed doctors and beauty experts.

For more about Haute Beauty, visit https://hauteliving.com/hautebeauty/

Share article on social media or email:

Gravitas Medical Announces US FDA Clearance of the Entarik Platform


The Entarik System is designed to provide an alert when a nasogastric tube migrates so that ICU clinical staff can make timely decisions that assist in avoiding complications.

Gravitas Medical today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of its innovative Entarik Feeding Tube System and Feeding Tube. This innovative enteral nutrition delivery system is set to be the first of many products that Gravitas will introduce that will transform enteral feeding into enteral intelligence. “Our mission is to use technology to replace the current nutrition delivery solutions with an enteral nutrition intelligence platform that helps caregivers make timely decisions for their patients, and this marks the beginning of that transformation,” said Saheel Sutaria, CEO of Gravitas Medical.

The system consists of a “smart” nasogastric tube equipped with sensors designed to provide information about the location of the tube tip relative to the stomach and a monitor that continuously monitors the position of the tube during the course of feeding. The system assists in reducing the incidence of misplacement during first positioning and provides real-time alerts of tube migration. “There is risk to the patient when a feeding tube migrates from the stomach to the esophagus,” said Sutaria. “The Entarik System is designed to provide an alert when a nasogastric tube migrates so that ICU clinical staff can make timely decisions that assist in avoiding complications.”

“We are thrilled to bring this innovative new product to market”, said Jim Gabalski, Vice President of Marketing and Sales. “The use of enteral feeding is rising as hospitals care for an increasing number of patients with head and neck cancer, stroke, and other conditions that inhibit normal food intake. Entarik provides an easy-to-use platform that will expand in capability to provide ICU teams with timely information, enabling better decisions, improved outcomes, and shorter lengths of stay.”

Gravitas Medical will be attending the American Society for Parenteral and Enteral Nutrition (ASPEN) Conference in Las Vegas on April 20-23, 2023 where interested Enteral Nutrition professionals will be able to get a first look at Entarik.

About Gravitas Medical

Gravitas Medical is a Silicon Valley-based medical device company that emerged out of Theranova, a MedTech incubator focused on tackling the biggest challenges in healthcare. Gravitas Medical is focused on transforming enteral feeding into enteral nutrition intelligence. The gut provides information and Gravitas uses use its passion for technology to find new ways to gather that information and provide it to caregivers so that they can make better decisions, improve outcomes for their patients, reduce the amount of time a patient stays in the hospital, and reduce the overall cost of care. They take the guesswork out of enteral nutrition.

Share article on social media or email:

ARC (Association of Related Churches) Featured in Special Edition of Avail Journal: “Inside the ARC”


ARC (Association of Related Churches) is excited to announce that the organization has been featured in a recent edition of the Avail Journal.

The entire Avail Journal magazine is dedicated to voices throughout the ARC church family for this edition. Readers can learn how ARC (Association of Related Churches) started, updates from recent ARC church planters, and leadership articles on topics related to culture, diversity, ministry, and church planting.

Avail Journal is a quarterly magazine dedicated to helping leaders in business and ministry refine the art of leadership so they can make be more impactful around the globe. The goal of the publication is to help readers discern the changing context in which they serve, how to seize opportunities, and how to do so in a way that is true to the unique gifts and creativity God has placed within everyone.

The magazine wanted to partner with ARC (Association of Related Churches) on this Special Edition collaboration to share the organization’s impressive story of how they transform communities through church planting. By being featured in Avail Journal, the organization expands its reach to a new audience of church leaders around the globe who could be potential future leaders of ARC churches.

Dino Rizzo, the executive director of ARC (Association of Related Churches), served as the Guest Editor of this Special Edition of Avail Journal. He wrote an introductory article explaining the organization, where it came from, and where it’s going.

Among the many insights, Rizzo shares are three takeaways that have set up the organization for success and values other networks and movements can adopt for sustainability and effectiveness. As he writes:

“It really is about relationships … It’s about a big field and not a little pasture … It’s about creating a resource-rich environment from church planters.”

In addition to Rizzo’s note, the “Inside the ARC” Special Edition of Avail Journal includes an article by Ken Walker, “The Next 1,000,” discussing how to build on a winning formula for planting healthy ARC churches; a story by Andy Butcher, “The Fight for Rest,” which discusses Greg Surratt’s mission to take down pastoral burnout; insights from Irene Rollins, “Reframe Your Shame,” about how God turns struggles into strength; and much, much more.

This Special Edition of Avail Journal will be distributed at the ARC Conference scheduled for April 25-26 in Birmingham, Alabama, as well as other events held by ARC (Association of Related Churches). It will also be available to all of Avail’s subscribers.

About ARC (Association of Related Churches)

ARC (Association of Related Churches) is a cooperative of independent churches from different denominations, networks, and backgrounds who strategically resource church planters and pastors to help them reach people with the message of Jesus. ARC exists to see a thriving church in every community, reaching people with the message of Jesus. Since its beginning in 2000, ARC has grown into a global organization and has helped plant more than 1,000 churches.

Share article on social media or email:

American College of Lifestyle Medicine and National Board for Health & Wellness Coaching announce collaboration to advance the role of behavior change in health care


News Image

“Knowledge is important but, to achieve lasting behavior change, patients and clients also need coaching to motivate them and help them determine how to make and maintain lifestyle behavior changes to improve their health and wellbeing.”

The American College of Lifestyle Medicine (ACLM) and the National Board for Health & Wellness Coaching (NBHWC) have announced a strategic collaboration to advance behavior change and health and wellness coaching skills among health care professionals and enhance the role for health and wellness coaches on health care teams. The collaboration will provide an avenue for advancing research, education, and awareness to further uncover the benefits of coaching skills within the lifestyle medicine paradigm.

NBHWC, an affiliate of the National Board of Medical Examiners, provides board certification for health and wellness coaches. National Board Certified Health & Wellness Coaches (NBC-HWC) train in behavior change theories, motivational strategies, and health education and promotion theories. NBC-HWCs support clients in creating and sustaining change for improved health and well-being.

NBC-HWCs commonly work on health care teams alongside physicians and other clinicians as part of an integrative approach to patient and client care. Other NBC-HWCs work in digital health, community-based programs, or entrepreneurial capacities. NBHWC has board certified more than 8,400 health and wellness coaches.

ACLM and NBHWC are natural partners as many of the lifestyle behaviors that health and wellness coaches frequently address with patients and clients relate to the six pillars of lifestyle medicine—a whole food, plant-predominant eating pattern, physical activity, restorative sleep, stress management, avoidance of risky substances and positive social connections. Lifestyle medicine is a medical specialty that uses therapeutic lifestyle interventions as a primary modality to treat chronic conditions including, but not limited to, cardiovascular diseases, type 2 diabetes, and obesity.

“Evidence-based lifestyle behavior interventions are proven to treat, prevent and even reverse many chronic conditions, but simply telling a patient or client what lifestyle changes to make is not enough,” said ACLM President and Harvard Medical School Clinical Assistant Professor Beth Frates, MD, FACLM, DipABLM, who also is a certified health coach. “Knowledge is important but, to achieve lasting behavior change, patients and clients also need coaching to motivate them and help them determine how to make and maintain lifestyle behavior changes to improve their health and wellbeing. ACLM is delighted to partner with the National Board for Health & Wellness Coaching to ensure that more clinicians develop health coaching skills, become board certified and bring awareness to the vital role of health coaches on care teams.”

Like health and wellness coaching, the specialty of lifestyle medicine is experiencing rapid growth. Since certification began in 2017 by the American Board of Lifestyle Medicine (ABLM), 2,445 physicians in the U.S. have become board certified in lifestyle medicine, along with 946 other health professionals. Globally across 72 nations, 3,999 physicians are now certified as well as 1,255 other health professionals.

The White House Conference on Hunger, Nutrition and Health in September highlighted lifestyle medicine and ACLM for its commitment to offer complimentary CME/CE coursework on lifestyle and food as medicine to 100,000 physicians and other health professionals. In addition to this introductory course for all clinicians, ACLM also offers a variety of other coursework, including NBHWC-approved continuing education courses for board certified health coaches.

In addition to the strategic collaboration with ACLM, NBHWC has joined ACLM as a member of the Corporate Roundtable, a group of organizations and companies united in a shared commitment to address the burden of chronic disease through novel products and solutions focused on health care transformation.

“The NBHWC sees tremendous value in joining ACLM as a strategic collaborator and member of the Corporate Roundtable, as we wish to align with leaders who believe in the power of partnering with patients and clients to support healthy lifestyle choices,” said NBHWC Executive Director Leigh-Ann Webster, NBC-HWC. “We believe that board certified health and wellness coaches play an integral role on the health care team, and we’re thrilled to be a part of a movement that will lead to improved health and well-being for all.”

ABOUT ACLM

The American College of Lifestyle Medicine is the nation’s medical professional society advancing lifestyle medicine as the foundation for a redesigned, value-based and equitable healthcare delivery system, leading to whole person health. ACLM educates, equips, empowers and supports its members through quality, evidence-based education, certification and research to identify and eradicate the root cause of chronic disease, with a clinical outcome goal of health restoration as opposed to disease management. http://www.lifestylemedicine.org

Share article on social media or email:

NEDHSA assists Grandfather in protecting and providing for his family with DD services


NEDHSA assists Grandfather in protecting and providing for his family with DD services

NEDHSA assists Grandfather in protecting and providing for his family with DD services

“Through talking on the phone, in-person visits, and communicating via email, Mr. Thornton and I work together to make sure Jordan is getting the services he needs,” Talley said.

Clint Thorton is a retired ceramic tile contractor, retired student teacher, and Director of Music at his church. After losing his wife to Huntington’s Disease, Thornton has spent his life as a single father of four children and, in recent years, a dedicated and compassionate grandfather who is the sole caretaker of his 23-year-old grandson Jordan Wilcockson.

Wilcockson was born handsome, healthy, and happy. However, the environment and conditions he was born into were incredibly unfit, causing extreme concern for Thorton. Wilcockson’s mother, Thorton’s daughter, has Huntington’s Disease, and in addition, Wilcockson grew up in a domestically abusive home. So much so that at two months old, Wilcockson became a victim of Shaken Baby Syndrome.

Victims of shaken baby syndrome vary with the severity of the injury. However, many cases are fatal or lead to severe neurological deficits such as Cerebral palsy, paralysis, vision loss or blindness, intellectual disability, epilepsy, or seizures. Parenthood is considered the biggest challenge in one’s life.

“It is hard for a single parent to raise children,” Thorton said. “But harder for a child in my grandson’s condition.”

Thorton did not let the foreseen struggles, complications, and financial strain deter him from protecting and providing for his grandson. The family’s relationship with Northeast Delta Human Services Authority (NEDHSA) began when Thorton received custody of Wilcockson when he was eight months old. Wilcockson’s diagnosis requires around-the-clock total care. Thorton loves his grandson and will do all he can, but there is only so much a grandfather can do alone; hence, NEDHSA services and resources were made available through Chasity Talley, Registered Nurse (RN).

“Mr. Thornton exemplifies what being an advocate for someone unable to speak for themselves genuinely means,” Talley said. “It is always such a pleasure to work with Mr. Clint Thornton.”

Talley, a NEDHSA Medical Certifications Specialist, works closely with the family to ensure needs are met by identifying areas of deficiencies, gaps in supplies, and any hindrances from comfortable daily living that allow Jordan to continue living in his family home.

“Through talking on the phone, in-person visits, and communicating via email, Mr. Thornton and I work together to make sure Jordan is getting the services he needs,” Talley said.

As a result of his ongoing and significant needs, Wilcockson was ruled eligible for the New Opportunities Waiver (NOW), which utilizes Medicaid funds to pay for much of his care. Through the NOW, the family can utilize private provider agencies or participate in Self-Direction Services for nursing services, individualized and family support services, environmental accessibility adaptations and any of the many other services available through this Waiver program.

At one point, Wilcockson’s care went from a combined 24 hours of nurse and personal care assistance staffing to four days a week, a total of 10 hours after moving from the city to a rural region. However, Talley was able to work with his support team and obtain approval for his personal care assistance back to 24 hours, lifting a significant burden on the family’s shoulders.

With the services and resources provided through NEDHSA, Thorton has hired and trained the direct support professionals to meet his grandson’s needs. The NOW also assists with funding for environmental modifications inside and outside of their home. With NEDHSA assistance in coordination and utilization of various funding sources including the NOW and Family Support funds, Wilcockson acquired a new wheelchair and personal care items when Medicaid funding no longer paid for those items.

“I know that neither my grandson nor I would have survived without 24-hour care, supplies, and God’s grace through it all,” Thorton said.

“Regardless of what services are needed all hands are on deck to assist in making sure that Jordan gets the services and care he needs to live his best life,” Talley said.

Share article on social media or email:

Recent Study Indicates Hospitals Excessively Transfuse Blood


Columbia Healthcare Analytics Logo

Columbia Healthcare Analytics Logo

“This study is valuable and timely to hospital systems around the globe. Transfusing blood from donors can transmit infections and can increase morbidity and death due to several other factors. Additionally, costs in healthcare and staffing needs are exacerbated by unnecessary treatments.”

Columbia Healthcare Analytics, Inc. released their recently published study results that indicate the need for additional education in blood transfusions.

According to a new retrospective sample 15-hospital clinical study published January 10th, 2023, in the Joint Commission Journal of Quality and Patient Safety (JCJQPS), as many as ninety-two percent of patients receiving a blood transfusion could likely receive much less blood. Forty-five percent of transfused patients could be adequately managed without any blood transfusion.

This study supports earlier findings and suggests a need for additional due diligence regarding blood transfusions.

Dr. David Jadwin, Founder and CEO of Columbia Healthcare Analytics, explains, “many contributing and recent factors include advances in patient blood management like hematinics (IV iron and erythropoietin) and pharmaceutical products that help control bleeding. Additionally, blood can be “salvaged” by collection and washing, after which doctors can return the patient’s blood rather than transfusing blood collected by local donor centers.”

The reported study attributes the high rate of avoidable transfusions to several physician-related factors.

For blood transfusion, the indications are typically based upon a laboratory value, commonly a hemoglobin value less than seven g/dL, or a “bleeding” indication. However, physicians are learning that patients can tolerate much lower hemoglobin values if adequately supported.Dr. Jadwin further states, “This study is valuable and timely to hospital systems around the globe.

Transfusing blood from donors can transmit infections, such as HIV and hepatitis, and can increase morbidity and death due to several other factors. Additionally, costs in healthcare and staffing needs are exacerbated by unnecessary treatments.”

This study will be used to appropriately educate physicians to use less blood.

To read the complete study, go to the following: https://www.jointcommissionjournal.com/article/S1553-7250(22)00246-X/fulltext

Columbia Healthcare Analytics, Inc. conducted this study. The results were partly verified using a panel of 10 independent physician reviewers.

About Columbia Healthcare Analytics, Inc.

Columbia Healthcare Analytics, Inc. has developed an anonymized medical review network that provides objective peer review, rapidly improving patient care. Our External Review as a Service (ERaaS™) technology ensures a standardized review that offers mentoring feedback for physicians. Anonymized patient care data for any medical care is analyzed in a HIPAA-compliant setting, which enables accurate regional and national performance measures. Our peer review network ensures that all participants are evaluated consistently and objectively and overcomes issues when physicians perform their own internal peer review. Gamification and incentives ensure optimal physician engagement and reward good patient management. ERaaS™ technology provides unsurpassed immediate and sustained patient care improvement.

Share article on social media or email: